knowledge -WSS

knowledge

author：knowledge 2025-09-02 11:46:21 - browse：6

Monica Bertagnolli -- Health Policy coverage from STAT — Monica Bertagnolli, the nominee to lead the National Institutes of Health Jeff Chiu/AP

Monica Bertagnolli, President Biden’s nominee to lead the National Institutes of Health, spent her confirmation hearing Wednesday stuck in the middle of Republicans’ and Democrats’ bickering over her agency’s role in high drug costs, ultimately refusing to commit to either party’s approach.

Bertagnolli similarly walked a line on government funding for gender-affirming care research and other hotly politicized health care issues, though she did stress that transgender youth are some of the country’s most vulnerable people.

The long-awaited hearing came months after Committee Chairman Bernie Sanders (I-Vt.) pledged to stall her confirmation process until Biden did more to address high drug prices, like an assurance that the NIH would insert reasonable pricing requirements into deals with commercial drugmakers.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Children’s Hospital revives plan for pedestrian bridge

WSS

Flu, Covid vaccination rates decline, new survey data show

The United States is paying nearly triple for new Covid vaccines

6 solutions to address cancer drug shortages and others

CDC panel: People 65 and older should get a Covid spring booster shot

'Vaccine

Color Health wants to make cancer screenings convenient

focus

knowledge

explore

United colonoscopy coverage change 'may cost lives,' doctors say

Setback for rare diseases as Taysha Gene Therapies pulls back

At least 13 dead in Texas as scorching temps continue

2023 Nobel Prize in Medicine goes to Karikó and Weissman

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Health insurers' Q3 question: how much care are people getting?

Hepatitis C has a cure — but many Americans still lack access to it

What we owe ALS patients — and why one company fell short

Bright Health sells Medicare Advantage business to Molina

Study fuels hope CAR

entertainment

6 solutions to address cancer drug shortages and others

'Vaccine

Medicare isn't yet testing food as medicine

Readout Newsletter: Beam, Prozac, "TechBio" and more

5 ways to address the shortage of health care workers

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

leisure time

hotspot

Wikipedia

focus